| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |